Common, Yet Overlooked Skin Conditions
Dermatologists treat more than 3,000 conditions, but not all of them receive equal attention. In this Next Steps in Derm video interview, in partnership with the ODAC Dermatology Conference, ODAC Conference Co-Chair Adam Friedman, MD, FAAD, addresses common, yet overlooked skin conditions, most of which do not have FDA-approved therapies. Watch and learn tips for the creative management of lichen …
Dermatologists treat more than 3,000 conditions, but not all of them receive equal attention. In this Next Steps in Derm video interview, in partnership with the ODAC Dermatology Conference, ODAC Conference Co-Chair Adam Friedman, MD, FAAD, addresses common, yet overlooked skin conditions, most of which do not have FDA-approved therapies. Watch and learn tips for the creative management of lichen … 
Managing rosacea requires moving beyond quick, symptomatic fixes toward a comprehensive framework that addresses the entire scope of the disease. In a recent presentation, Adam Friedman, MD, FAAD—Professor and Chair of Dermatology at The George Washington University School of Medicine & Health Sciences—outlined an updated clinical approach to diagnosing and managing rosacea. From recognizi … 
At the 2026 ODAC Dermatology conference, Dr. Adam Friedman opened his session on prurigo nodularis (PN) with a patient case that felt familiar to many of us. A patient with multiple nodules, relentless itch, and one central question. Why is this happening?
This patient case reminds us that prurigo nodularis is not simply the result of scratching or a sequela of another inflammatory disease. It … 
At the 2026 ODAC Dermatology Conference, we had the privilege of learning about chronic spontaneous urticaria (CSU) from Dr. Adam Friedman, MD, FAAD, Professor and Chair of Dermatology at The George Washington University School of Medicine. CSU can be a maddening, exhausting condition for patients, with a relapsing disease course and without identifiable triggers. Given that symptoms are often abs … 
Derm In-Review, a top dermatology board review prep course, recently took learning on the road to Harvard. A Dermatology In-Review Live Board Review Workshop was held in May at Massachusetts General Hospital, Harvard Medical School’s oldest and largest teaching hospital, with resident attendees from the hospital as well as Boston University and the University of Massachusetts. Sanofi Regeneron s …